Dear members of the WG on Atherosclerosis and Vascular Biology,
As spring is in the air and our research teams are in full productivity mode, we are proud to highlight this month's most noteworthy papers in our newsletter, each offering invaluable insights into the multifaceted world of atherosclerosis research. These papers, meticulously curated by leading experts in the field, serve as a testament to the depth and breadth of scientific inquiry within our community.
From microplastics that end up in atherosclerotic plaques and aggravate the disease (doi: 10.1056/NEJMoa2309822), to novel insights into sphingolipid metabolism and endothelial function in coronary artery disease (doi: 10.1161/CIRCRESAHA.123.323826), in-depth insights into the role of TREM2+ macrophages in atherosclerosis (doi: 10.1038/s44161-024-00429-9), to insights on how atherosclerotic cardiovascular disease is spreading and being controlled in Africa (doi: 10.1093/cvr/cvad173), these articles are a must-read for anyone seeking to stay at the forefront of cardiovascular science.
Other recommended reading from our team include:
Predicting Lipid-rich plaque progression in coronary arteries using multimodal imaging and wall shear stress signatures (doi: 10.1161/ATVBAHA.123.320337).
Smooth muscle cell-specific matrix metalloproteinase 3 deletion reduces osteogenic transformation and medial artery calcification (doi: 10.1093/cvr/cvae035).
High-dimensional single-cell multimodal landscape of human carotid atherosclerosis (doi: 10.1161/ATVBAHA.123.320524).
Hallmarks of cardiovascular ageing (doi: 10.1038/s41569-023-00881-3)
Tackling inflammation in atherosclerosis (doi: 10.1038/s41569-024-01007-z)
Immune and inflammatory mechanisms in hypertension (doi: 10.1038/s41569-023-00964-1)
The European Society of Cardiology (ESC) has organised two landmark events that promise to shape the future of cardiovascular medicine. In addition to our upcoming spring conference, Frontiers in Cardiovascular Biomedicine, set to take place in Amsterdam from 12 to 14 April, we are also preparing for the 2024 ESC Congress in London, from 30 August to 2 September.
Frontiers in Cardiovascular Biomedicine, our spring conference in Amsterdam, will serve as a launchpad for groundbreaking discoveries and includes cutting-edge research in the field of atherosclerosis. With a focus on unravelling the complexities of cardiovascular disease and exploring novel therapeutic avenues, this conference is a must-attend event for anyone committed to advancing the frontiers of cardiovascular science.
Access the scientific programme
At the major annual ESC Congress 2024, attendees can expect a diverse and stimulating programme, featuring a wide range of sessions, symposia, and workshops covering the full spectrum of cardiovascular science and clinical practice. From groundbreaking research presentations to hands-on training sessions, the ESC Congress in London will showcase the latest advancements in cardiovascular medicine and provide insights into the future direction of the field.
Access the scientific programme
We look forward to welcoming you to Frontiers in Cardiovascular Biomedicine in Amsterdam and ESC Congress 2024 in London, where together, we will shape the future of cardiovascular medicine.
We wish you all a happy and productive spring!
Isabel Goncalves (Communication coordinator) and Esther Lutgens (Chair), ESC WG on Atherosclerosis and Vascular Biology
Our mission: To reduce the burden of cardiovascular disease.